1月27日,美国医疗保险与医疗补助服务中心(CMS)公布第三轮《通胀削减法案》(IRA)药品价格谈判名单,共15款药物。这些药物2024年11月至2025年10月期间在Medicare Part B和Part D的总支出约270亿美元,涉及180万患者。这是IRA价格谈判首次纳入Part B(医师给药)产品,标志法案覆盖范围进一步扩大。随着年初首批纳入Medicare价格谈判的药品成本降低措施成功...
Source Link1月27日,美国医疗保险与医疗补助服务中心(CMS)公布第三轮《通胀削减法案》(IRA)药品价格谈判名单,共15款药物。这些药物2024年11月至2025年10月期间在Medicare Part B和Part D的总支出约270亿美元,涉及180万患者。这是IRA价格谈判首次纳入Part B(医师给药)产品,标志法案覆盖范围进一步扩大。随着年初首批纳入Medicare价格谈判的药品成本降低措施成功...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.